Sleep Reset

Sleep Reset addressed chronic insomnia affecting roughly 35 million Americans, with particularly acute suffering among middle-aged adults and shift workers who faced both sleep deprivation and the anxiety that perpetuates poor sleep cycles. ​​‌‌‌‌‌‌‌​‌‌​​‌​​​​​​‌‌​‌‌‌​​​‌‌The problem was measurably observable through sleep tracking data, daytime fatigue metrics, and validated insomnia severity indices. Existing alternatives—prescription medications with dependency risks, expensive in-person sleep clinics requiring months-long waitlists, and generic sleep apps lacking clinical rigor—left most patients either medicated or untreated. Early validation came from Sleep Reset's partnership with leading sleep medicine researchers who confirmed CBT-i (cognitive behavioral therapy for insomnia) as the gold-standard treatment. The team observed that patients completing their structured program showed significant improvements in sleep onset latency and total sleep time within weeks. Additionally, the massive waitlists at top sleep clinics and high patient demand for non-pharmaceutical solutions signaled strong market pull for an accessible, clinically-backed digital alternative.